Companies / Indonesia
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Pharmaceutical Market Cools
March 2007 | Industry ForecastSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
BMI has slightly downgraded its forecast for the Indonesian pharmaceutical market after official figures showed contraction in the last quarter of 2006, primarily as a result of decreasing public purchasing power and generic drug price cuts earlier in the year. According to the country's association of drugmakers - GP Farmasi - IDR24trn (US$2.6bn) was spent on medicines last year, which represented an 8.6% rise compared to 2005 (2004/05 growth equalled 12%). However, growth in Q406 was 3% down on the same period in the previous year, suggesting that the market is